Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aurobindo Pharma receives USFDA approval for Tofacitinib Tablets
The product will be manufactured at APL Healthcare Unit IV, a wholly owned subsidiary of the company and will be launched immediately.
Aurobindo Pharma gets final FDA nod for tofacitinib tablets which target rheumatoid arthritis
The tablets will be manufactured at APL Healthcare unit IV, a wholly-owned subsidiary of the company, and will be launched immediately. Shares of Aurobindo Pharma Ltd ended at ₹1,467, up by ₹26.70, or 1.85%, on the BSE today, June 4.
PE wars to billion-dollar IPO dreams, hospital sector is fighting fit
Major private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition highlights strong investor confidence in India's healthcare sector. The industry is entering a new growth phase driven by increasing demand, a shortage of hospital beds, and a rise in specialized medical services.
Hexaware Technologies inks strategic collaboration with HBSUK
Hexaware Technologies announced a strategic collaboration with UK-based healthcare services provider HBSUK to enhance the latter's workforce management proposition.
Apollo Hospitals Takes Rs 100-Crore Hit On Middle-East Conflict; HealthCo Demerger By Year-End
Apollo HealthCo houses the pharmacy distribution, digital health and omnichannel healthcare businesses
BofA sees domestic growth, Semaglutide opportunity driving pharma in FY27
Neha Manpuria, Senior Analyst - Pharma, Healthcare at BofA Global Research, says semaglutide launches could emerge as a key growth driver for Indian pharma companies in FY27.
Asia Healthcare Holdings eyes IPO within 18 months amid market concerns - Investing.com India
Asia Healthcare Holdings eyes IPO within 18 months amid market concernsInvesting.com India
Tejnaksh Healthcare standalone net profit declines 33.33% in the March 2026 quarter
Sales decline 26.25% to Rs 1.77 crore
Leapfrog, IFC and NIIF eye ₹400 crore minority stake in Marengo Asia Healthcare
Marengo will likely use the proceeds to fund its next level growth phase, including inorganic growth plans and expanding its Gurgaon and Faridabad capacity
India's out-of-pocket healthcare spending drops significantly, govt data shows
Indian families now pay less for healthcare. Out-of-pocket spending fell from 64.2% to 43.4% in ten years. This is due to the government spending more on public health. Government health expenditure as a share of GDP has also increased. Per capita spending on health has grown significantly. This shows a stronger health financing safety net for citizens.
Out-of-pocket expenditure share declines by 21 percentage points from 2013-14: Health ministry
Government health spending has risen, leading to a significant drop in out-of-pocket health expenses. This decline, from 64.2% in 2013-14 to 43.4% in 2022-23, shows improved access to healthcare. Initiatives like Ayushman Arogya Mandir provide free services, reducing household financial burdens.
Tata Elxsi launches AnaTel, an AI native software development platform
For healthcare and medical technology companies